Results 101 to 110 of about 2,809,929 (262)
Familial effort polymorphic ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy are linked to chromosome 1q42 ...
DANIELI, GIAN ANTONIO +18 more
core +1 more source
Background Electrocardiographic abnormalities are common in arrhythmogenic right ventricular cardiomyopathy and are included in the 2010 Task Force Criteria. Their time course, however, remains uncertain.
Anneli Svensson +11 more
doaj +1 more source
FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy
Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disease that affects predominantly the right ventricle and is part of the spectrum of arrythmogenic cardiomyopathies (ACMs).
F. Brun +10 more
semanticscholar +1 more source
Abstract Background and Purpose Doxorubicin (DOX) is a highly effective anthracycline, whose clinical application for cancer is limited by cardiotoxicity. The mechanisms underlying doxorubicin‐induced toxic cardiomyopathy (DICM) involve electrophysiological remodelling with intracellular Na+ overload because of increased late INa and hyperactivation of
Anna‐Lena Feder +7 more
wiley +1 more source
Arrhythmogenic Right Ventricular Cardiomyopathy: Diagnosis, Risk Stratification, and Treatment. [PDF]
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic heart disease with a prevalence of 1 : 2000 to 1 : 5000. It is characterized by the progressive replacement of heart muscle tissue by fatty and connective tissue. It is associated with a high risk of sudden cardiac death.
Kreimer F +5 more
europepmc +4 more sources
Phenotype‐directed gene panel testing and opportunistic ACMG SF v3.3 screening identified distinct, complementary cardiovascular genetic risks in a Korean cohort. Panel testing achieved a 20.0% yield enriched for arrhythmia/cardiomyopathy genes, whereas opportunistic exome screening revealed a 5.6% yield dominated by TTN‐related cardiomyopathy and ...
Jihye You +3 more
wiley +1 more source
Arrhythmogenic right ventricular cardiomyopathy, a genetically inherited disease that results in fibrofatty replacement of normal cardiac myocytes, has been associated with sudden cardiac death in athletes.
Ibhar Al Mheid +4 more
core +1 more source
Domenico Corrado *, Peter J. van Tintelen, William J. McKenna, Richard N.W. Hauer, Aris Anastastakis, Angeliki Asimaki, Cristina Basso, Barbara Bauce, Corinna Brunckhorst, Chiara Bucciarelli-Ducci, Firat Duru, Perry Elliott, Robert M.
D. Corrado +39 more
semanticscholar +1 more source
ABSTRACT Introduction In patients with ischemic cardiomyopathy (ICM), recurrent VF may be treated with catheter ablation by targeting triggering premature ventricular complexes (PVCs) and/or ventricular scar homogenization. Data on optimal ablation strategies in patients with non‐ischemic cardiomyopathy (NICM) remain limited.
Kenji Hashimoto +2 more
wiley +1 more source
Arrhythmogenic Cardiomyopathy: History and Pathology
Arrhythmogenic right ventricular cardiomyopathy dysplasia (ARVC/D) is a life-threatening entity, which has drawn the attention of the scientific community for the last 30 years since it is a significant cause of premature death.
PILICHOU, KALLIOPI +7 more
core +1 more source

